CN113694128B - Response surface method optimized extraction process of strychnine-containing alkaloids in carex meyeriana - Google Patents
Response surface method optimized extraction process of strychnine-containing alkaloids in carex meyeriana Download PDFInfo
- Publication number
- CN113694128B CN113694128B CN202110848038.4A CN202110848038A CN113694128B CN 113694128 B CN113694128 B CN 113694128B CN 202110848038 A CN202110848038 A CN 202110848038A CN 113694128 B CN113694128 B CN 113694128B
- Authority
- CN
- China
- Prior art keywords
- alkaloids
- extraction
- strychnine
- alkaloid
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 title claims abstract description 106
- 229930013930 alkaloid Natural products 0.000 title claims abstract description 102
- 238000000605 extraction Methods 0.000 title claims abstract description 74
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 title claims abstract description 54
- 241001279009 Strychnos toxifera Species 0.000 title claims abstract description 52
- 229960005453 strychnine Drugs 0.000 title claims abstract description 52
- 230000004044 response Effects 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims abstract description 20
- 241000045459 Carex meyeriana Species 0.000 title 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000007787 solid Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 238000010898 silica gel chromatography Methods 0.000 claims abstract description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 63
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 42
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 39
- 239000003153 chemical reaction reagent Substances 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 23
- 239000000284 extract Substances 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 238000002474 experimental method Methods 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 9
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 238000000746 purification Methods 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 7
- 239000000741 silica gel Substances 0.000 claims description 7
- 229910002027 silica gel Inorganic materials 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- -1 alkaloid salts Chemical class 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- 238000005211 surface analysis Methods 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- 238000004809 thin layer chromatography Methods 0.000 abstract description 6
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 4
- 244000025254 Cannabis sativa Species 0.000 abstract description 3
- 238000010993 response surface methodology Methods 0.000 abstract description 2
- 238000013401 experimental design Methods 0.000 abstract 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 abstract 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 19
- 239000000523 sample Substances 0.000 description 17
- 239000013558 reference substance Substances 0.000 description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 11
- 238000010586 diagram Methods 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- DKNPRRRKHAEUMW-UHFFFAOYSA-N Iodine aqueous Chemical compound [K+].I[I-]I DKNPRRRKHAEUMW-UHFFFAOYSA-N 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 3
- 229940093265 berberine Drugs 0.000 description 3
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 229930003347 Atropine Natural products 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 2
- 239000011609 ammonium molybdate Substances 0.000 description 2
- 229940010552 ammonium molybdate Drugs 0.000 description 2
- 235000018660 ammonium molybdate Nutrition 0.000 description 2
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 2
- 229960000396 atropine Drugs 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 229960004126 codeine Drugs 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 2
- 229930005303 indole alkaloid Natural products 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001233914 Chelidonium majus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000007235 Cyanthillium patulum Species 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 244000152045 Themeda triandra Species 0.000 description 1
- FVECELJHCSPHKY-WTFKENEKSA-N Veratrine (amorphous) Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)O[C@@H]1[C@]2(O)O[C@@]34C[C@@]5(O)[C@H](CN6[C@@H](CC[C@H](C)C6)[C@@]6(C)O)[C@]6(O)[C@@H](O)C[C@@]5(O)[C@@H]4CC[C@H]2[C@]3(C)CC1 FVECELJHCSPHKY-WTFKENEKSA-N 0.000 description 1
- UEJQQMLXZQUJHF-UHFFFAOYSA-L [K+].[I+].[I-].[I-] Chemical class [K+].[I+].[I-].[I-] UEJQQMLXZQUJHF-UHFFFAOYSA-L 0.000 description 1
- LWQAYTWMEQUUFP-UHFFFAOYSA-K [K].I[Bi](I)I Chemical compound [K].I[Bi](I)I LWQAYTWMEQUUFP-UHFFFAOYSA-K 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- ONBIUAZBGHXJDM-UHFFFAOYSA-J bismuth;potassium;tetraiodide Chemical compound [K+].[I-].[I-].[I-].[I-].[Bi+3] ONBIUAZBGHXJDM-UHFFFAOYSA-J 0.000 description 1
- UWGBIKPRXRSRNM-UHFFFAOYSA-N cevadine Natural products CC=C(C)/C(=O)OC1CCC2(C)C3CCC4C5(O)CC(O)C6(O)C(CN7CC(C)CCC7C6(C)O)C5(O)CC24OCC13O UWGBIKPRXRSRNM-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000035418 detection of UV Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000000409 membrane extraction Methods 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000012803 optimization experiment Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
采用响应面分析方法确定酸水法提取乌拉草中含有士的宁生物碱的最佳提取工艺并对其进行鉴别。选取提取温度、料液比和盐酸浓度三个因素,以乌拉草总生物碱提取率为响应值,进行Box‑Benhnke试验设计。最佳提取工艺为:提取时间2h,盐酸浓度为0.18 mol/L、提取温度为80℃、液料比为30 mL/g,生物碱提取率可达到2.74%。通过硅胶柱层析纯化分离生物碱,理化性质鉴定,运用紫外分光光度法鉴定、薄层色谱法鉴定、高效液相色谱法鉴定证明乌拉草生物碱中存在士的宁。Response surface methodology was used to determine the optimal extraction process of strychnine alkaloids from Ula grass by acid-water method and to identify them. Three factors, extraction temperature, material-to-liquid ratio and hydrochloric acid concentration were selected, and the extraction rate of total alkaloids from uran grass was the response value, and the Box-Benhnke experimental design was carried out. The optimal extraction process is as follows: extraction time is 2h, hydrochloric acid concentration is 0.18 mol/L, extraction temperature is 80℃, liquid-solid ratio is 30 mL/g, and the extraction rate of alkaloids can reach 2.74%. The alkaloids were purified and separated by silica gel column chromatography, identified by physicochemical properties, identified by UV spectrophotometry, identified by thin layer chromatography, and identified by high performance liquid chromatography to prove the presence of strychnine in urax alkaloids.
Description
技术领域technical field
本发明涉及一种优化生物碱的提取方法,以及生物碱中士的宁的鉴别方法。The invention relates to an extraction method for optimizing alkaloids and a method for identifying strychnine in alkaloids.
背景技术Background technique
乌拉草作为一种古老的植物,其含有丰富的生物活性成分,是珍贵的植物资源。广泛分布于中国东北部、四川、内蒙古、俄罗斯东部等地,在医药、保健等领域具有广阔的发展前景。乌拉草有奇特的保暖功能以及透气、防寒、抑菌等功能。目前,对乌拉草的研究主要集中在纤维等物理性质方面,鲜有对其提取液的化学成分的研究。草提取物中常含有生物碱,而大多数生物碱都具有抗癌、抗肿瘤、抗炎、抗病毒以及抗血小板凝集、抗心律失常以及抗高血压等心血管疾病的作用。As an ancient plant, Ulagrass contains rich bioactive components and is a precious plant resource. Widely distributed in Northeast China, Sichuan, Inner Mongolia, Eastern Russia and other places, it has broad development prospects in the fields of medicine and health care. Ulagrass has a unique function of keeping warm, breathable, cold-proof, and antibacterial. At present, the research on Uralia ulata mainly focuses on the physical properties such as fiber, and there is little research on the chemical composition of its extract. Grass extracts often contain alkaloids, and most alkaloids have anti-cancer, anti-tumor, anti-inflammatory, anti-virus and anti-platelet aggregation, anti-arrhythmia and anti-hypertensive effects on cardiovascular diseases.
文献报道天然产物中生物碱目前的提取方法有水提取法、酸性水溶液提取法、碱性水溶液提取法、有机溶剂提取法、冷浸提法、回流提取法、索式提取法、超声波提取法、膜提取法、超临界提取法。生物碱的提取率和化学成分受很多因素的影响,常采用正交实验法或者响应面分析法来优化提取工艺,确定最佳提取条件。如赵胜男等人选取盐酸浓度、料液体积和提取温度三个因素,以总生物碱的得率为响应值,进行响应面试验设计,得出白屈菜生物碱的最优提取条件为盐酸浓度0.42%,料液体积97.59ml,提取温度50.12℃,在此条件下得到的生物碱为2.7090mg·g-1。马志宏等人采用正交试验选取提取时间、料液比、pH值和温度考察对红茂草总生物碱提取率的影响,得出酸水提取红茂草总生物碱的最佳条件为温度90℃,提取时间5h,料液比1:40,pH值1.5为提取红茂草总生物碱的最佳条件,并得出异紫堇碱提取率为9.28%。The literature reports that the current extraction methods of alkaloids in natural products include water extraction, acidic aqueous solution extraction, alkaline aqueous solution extraction, organic solvent extraction, cold leaching extraction, reflux extraction, Soxhlet extraction, ultrasonic extraction, Membrane extraction method, supercritical extraction method. The extraction rate and chemical composition of alkaloids are affected by many factors. Orthogonal experiments or response surface analysis are often used to optimize the extraction process and determine the best extraction conditions. For example, Zhao Shengnan and others selected the three factors of hydrochloric acid concentration, feed liquid volume and extraction temperature, took the yield of total alkaloids as the response value, and carried out response surface experiment design, and concluded that the optimal extraction condition of celandine alkaloids is the concentration of hydrochloric acid 0.42%, the volume of feed liquid is 97.59ml, and the extraction temperature is 50.12℃. The alkaloid obtained under these conditions is 2.7090mg·g -1 . Ma Zhihong et al. used orthogonal experiments to select the extraction time, solid-liquid ratio, pH value and temperature to investigate the influence on the extraction rate of the total alkaloids of the red grass. ℃, extraction time 5h, solid-liquid ratio 1:40, pH value 1.5 are the best conditions for extracting the total alkaloids of C. chinensis, and the extraction rate of isochoryline is 9.28%.
为了得到纯度较高的生物碱,将其纯化分离。生物碱经典的纯化方法包括有机溶剂萃取法、盐析法、沉淀法、结晶法、硅胶柱色谱与大孔吸附树脂法等。如潘扬等人采用溶剂提取、硅胶柱色谱等方法对马钱子发酵品的生物碱成分进行纯化分离,二氯甲烷-甲醇洗脱,按1%甲醇的梯度增加,依次洗脱,每个梯度5L,紫外灯下检视薄层板,改良碘化铋钾试剂显色,合并相同流分后,分成3%~4%甲醇、6%~7%甲醇、4%~5%甲醇和7%~15%甲醇4个洗脱部位,再反复进行硅胶或SephadexLH-20柱色谱分离、重结晶得到10种生物碱成分。In order to obtain alkaloids with higher purity, they are purified and separated. The classic purification methods of alkaloids include organic solvent extraction, salting out, precipitation, crystallization, silica gel column chromatography and macroporous adsorption resin method, etc. People such as Pan Yang use methods such as solvent extraction, silica gel column chromatography to purify and separate the alkaloid components of the fermented product of Nuxebra nuxe. Gradient 5L, inspect the TLC plate under ultraviolet light, improve the color development of bismuth potassium iodide reagent, combine the same fractions, divide them into 3%~4% methanol, 6%~7% methanol, 4%~5% methanol and 7% ~15% methanol for 4 elution sites, and then repeated silica gel or SephadexLH-20 column chromatography separation and recrystallization to obtain 10 alkaloid components.
士的宁属单萜吲哚生物碱类,是中药马钱子的有效成分,也是有毒成分,与马钱子碱二者约占生物碱的70%。历来研究结果显示士的宁为中强碱,在碱性环境下稳定,士的宁用酸液提取,再对酸液进行碱化萃取的提取方法。聂彦彦等人曾采用紫外分光光度法测量不同炮制方法(油炸法、奶制法、烘烤法、甘草制法、砂烫法)对马钱子中士的宁及马钱子碱的变化;曹玲等人采用TLC法对处方中马钱子进行定性鉴别;黄月纯等人采用反相高效液相色谱法,以甲醇-水(65:35)(水相含0.029mol·L-1磷酸二氢钾及0.037md·L-1十二烷基磺酸钠)为流动相,在检测波长为254nm下测定通痹灵片中士的宁的含量,得出保留时间在12min左右时供试品与对照品溶液均出现士的宁的吸收峰,测定峰面积计算每片通痹灵样品士的宁平均含量为0.22mg。Strychnine belongs to the class of monoterpene indole alkaloids, which is the active and toxic component of the traditional Chinese medicine Strychnine, accounting for about 70% of the alkaloids together with strychnine. Historical research results have shown that strychnine is a medium-strong base that is stable in an alkaline environment. The strychnine is extracted with an acid solution, and then the acid solution is subjected to an alkalized extraction method. Nie Yanyan and others used ultraviolet spectrophotometry to measure the changes of strychnine and strychnine in different processing methods (frying method, milk method, baking method, licorice method, sand scalding method); Cao Ling et al. used TLC method to qualitatively identify Nuxebra chinensis in the prescription; Huang Yuechun et al. used reversed-phase high-performance liquid chromatography, and used methanol-water (65:35) (the water phase contained 0.029mol L -1 diphosphate Potassium hydrogen and 0.037md L -1 sodium dodecylsulfonate) as the mobile phase, the content of strychnine in Tongbiling Tablets was measured at a detection wavelength of 254nm, and the test product was obtained when the retention time was about 12min Both the strychnine absorption peak and the reference substance solution appeared, and the average content of strychnine in each Tongbiling sample was calculated to be 0.22 mg by measuring the peak area.
至今,对乌拉草中生物碱的研究较少,未见对其提取工艺进行优化及结构方面进行相关报道。本申请专利则采用响应面设计方法以提取温度、料液比和盐酸浓度三个因素首次对乌拉草中生物碱进行考察,并经硅胶柱层析纯化分离,进行化学、光谱和色谱的方法鉴定,确定生物碱类化合物中含有士的宁。So far, there are few studies on the alkaloids in Uralia sativa, and there are no related reports on the optimization of its extraction process and its structure. This patent application adopts the response surface design method to investigate the alkaloids in Uralia sativa for the first time with the three factors of extraction temperature, solid-liquid ratio and hydrochloric acid concentration, and then purifies and separates them through silica gel column chromatography, and conducts chemical, spectroscopic and chromatographic identification. , to determine the alkaloids containing strychnine.
发明内容Contents of the invention
本发明的目的是提供一种响应面法优化乌拉草中总生物碱的提取方法以及士的宁的鉴别。The purpose of the present invention is to provide a response surface method to optimize the extraction method of total alkaloids in Ulagrass and the identification of strychnine.
为了解决上述问题,本发明提供了如下的技术方案。In order to solve the above problems, the present invention provides the following technical solutions.
(1)乌拉草烘干恒重后切段。(1) Ulagrass is dried to a constant weight and then cut into sections.
(2)用一定比例的酸水溶液提取2h,用纱布过滤,减压浓缩。将全部的乌拉草浓缩液,用40%氢氧化钠溶液调节pH值在8~10范围内,再用1:1体积的二氯甲烷进行萃取2次,合并萃取液用水洗涤直到除去溶于水的生物碱盐和碱水,收集萃取液浓缩干燥,得到粗生物碱。选取提取温度、液料比和盐酸浓度三个因素,以乌拉草总生物碱提取率为响应值,进行Box-Benhnke 试验设计,最佳提取工艺为:在提取时间2h下,盐酸浓度为0.18 mol/L、提取温度为80℃、液料比为30 mL/g,总生物碱提取率为2.74±1.0%。(2) Extract with a certain proportion of acid aqueous solution for 2 hours, filter with gauze, and concentrate under reduced pressure. Use 40% sodium hydroxide solution to adjust the pH value in the range of 8 to 10, and then extract twice with 1:1 volume of dichloromethane. The combined extracts are washed with water until the water-soluble alkaloid salt and alkaline water, and the extract was collected, concentrated and dried to obtain crude alkaloid. Select the three factors of extraction temperature, liquid-to-solid ratio, and hydrochloric acid concentration, and use the response value of the total alkaloid extraction rate of A. /L, the extraction temperature was 80°C, the liquid-to-solid ratio was 30 mL/g, and the extraction rate of total alkaloids was 2.74±1.0%.
(3)对得到的粗生物碱进行显色反应。显色反应现象分别为碘-碘化钾试剂有橙色沉淀产生、浓硫酸试剂显黄棕色、浓盐酸试剂不显色、钼酸铵-浓硫酸溶液(Frohde试剂)显棕绿色,说明乌拉草中存在生物碱。(3) Carrying out color reaction on the obtained crude alkaloid. The phenomenon of color reaction is that the iodine-potassium iodide reagent produces orange precipitate, the concentrated sulfuric acid reagent shows yellow-brown color, the concentrated hydrochloric acid reagent does not show color, and the ammonium molybdate-concentrated sulfuric acid solution (Frohde reagent) shows brown-green, indicating that there is biological alkali.
(4)经硅胶柱层析纯化与分离后得到乌拉草总生物碱。通过硅胶柱层析纯化分离生物碱,采用干法上样,硅胶与样品质量比为20:1,以石油醚:二氯甲烷:无水乙醇:环己烷(50:10:5:10)为洗脱剂洗脱三个柱体积,除极性较小的杂质;纯化更换洗脱剂为二氯甲烷:无水乙醇:环己烷(30:10:10)洗脱三个柱体积,洗脱出含有士的宁的纯化生物碱;最后用甲醇:二氯甲烷(40:10)洗脱其它极性大的生物碱,用生物碱沉淀试剂检测至洗脱样品无色。(4) After purification and separation by silica gel column chromatography, the total alkaloids of Uralia sativa were obtained. The alkaloids were purified and separated by silica gel column chromatography, and the sample was loaded by dry method. The mass ratio of silica gel to sample was 20:1, and petroleum ether: dichloromethane: absolute ethanol: cyclohexane (50:10:5:10) Elute three column volumes for the eluent to remove less polar impurities; purify and replace the eluent with dichloromethane: absolute ethanol: cyclohexane (30:10:10) to elute three column volumes, The purified alkaloids containing strychnine were eluted; finally, other alkaloids with high polarity were eluted with methanol:dichloromethane (40:10), and the eluted samples were detected to be colorless with an alkaloid precipitation reagent.
(5)化学方法鉴定士的宁:乌拉草生物碱酸水提取液经过浓缩、乙醇萃取后的样品用AB-8柱进行纯化分离,先以蒸馏水洗脱,再以70%乙醇洗脱,共洗脱下来5份生物碱样品。流份1是经水洗得到体积为50ml,流份2、3、4、5经醇洗得到每个体积各50ml。以1%的钒酸铵-浓硫酸溶液对每份生物碱样品及士的宁对照溶液进行颜色鉴别反应。流份3号与钒酸铵-浓硫酸溶液反应先出现紫色,后变为红色,出现的颜色变化与士的宁对照品相同。(5) Identification of strychnine by chemical method: after concentration and ethanol extraction of the alkaloid acid water extract, the sample was purified and separated by AB-8 column, first eluted with distilled water, and then eluted with 70% ethanol for a total of Five alkaloid samples were eluted.
(6)紫外、薄层及高效液相色谱鉴别,确定其中含有生物碱类化合物士的宁。纯化后的生物碱用甲醇溶解,紫外全波长扫描在254 nm处与士的宁对照品有相同的吸收峰;以二氯甲烷:环己烷:乙醇(3:1:1)为展开剂得出与士的宁对照品在薄层色谱板同一位置上,显示出相同颜色和形状的斑点;以0.4%磷酸(以三乙胺调制pH3.0)-乙腈(85:15)为流动相,检测波长为260nm,柱温25℃,梯度洗脱,得出与士的宁对照品在3.47min处有相同的吸收峰,得出生物碱样品中含有士的宁。(6) Ultraviolet, thin-layer and high-performance liquid chromatography identification, it is determined that it contains the alkaloid compound strychnine. The purified alkaloids were dissolved in methanol, and the ultraviolet full-wavelength scanning had the same absorption peak as the strychnine reference substance at 254 nm; using dichloromethane:cyclohexane:ethanol (3:1:1) as the developing solvent to obtain Spots with the same color and shape as the strychnine reference substance were on the same position on the thin-layer chromatographic plate; 0.4% phosphoric acid (adjusted with triethylamine to pH 3.0)-acetonitrile (85:15) was used as the mobile phase, The detection wavelength is 260nm, the column temperature is 25°C, and the gradient elution results in the same absorption peak as the strychnine reference substance at 3.47min, indicating that the alkaloid sample contains strychnine.
附图说明Description of drawings
图1是显色反应鉴定结果图;Figure 1 is a diagram of the identification results of the color reaction;
图2是士的宁标准品浓度与吸光度标准曲线图;Fig. 2 is a standard curve figure of strychnine standard substance concentration and absorbance;
图3是不同盐酸浓度对乌拉草总生物碱浓度的单因素图;Fig. 3 is the univariate figure of different hydrochloric acid concentrations to the total alkaloid concentration of Uralia sativa;
图4是不同提取温度对乌拉草总生物碱浓度的单因素图;Fig. 4 is a single factor diagram of different extraction temperatures on the total alkaloid concentration of Uralia sativa;
图5是不同料液比对乌拉草总生物碱浓度的单因素图;Fig. 5 is the univariate diagram of different solid-liquid ratios to the total alkaloid concentration of Uralia sativa;
图6是溶剂浓度(a)、提取温度(b)、液料比(c)对总生物碱含量影响的响应面图;Figure 6 is a response surface diagram of the influence of solvent concentration (a), extraction temperature (b), and liquid-solid ratio (c) on the total alkaloid content;
图7是残差散点(d)、预测正态分布(e)、实际正态分布(f)的响应面预测模型图;Fig. 7 is the response surface prediction model diagram of residual scatter point (d), predicted normal distribution (e), actual normal distribution (f);
图8是钒酸铵-浓硫酸溶液鉴定结果图;Fig. 8 is the identification result figure of ammonium vanadate-concentrated sulfuric acid solution;
图9是乌拉草生物碱分离士的宁的紫外全波长扫描图;Fig. 9 is an ultraviolet full-wavelength scanning figure of strychnine separated from alkaloids of Uralia sativa;
图10是士的宁对照品紫外全波长扫描图;Fig. 10 is strychnine reference substance ultraviolet full-wavelength scanning figure;
图11是薄层色谱鉴别图(1为生物碱样品,2为士的宁对照品);Figure 11 is a TLC identification diagram (1 is an alkaloid sample, and 2 is a strychnine reference substance);
图12是乌拉草提取液的高效液相色谱图;Fig. 12 is the high-performance liquid chromatogram of Herba Ursa extract;
图13是士的宁对照品的高效液相色谱图。Fig. 13 is the high performance liquid chromatogram of strychnine reference substance.
具体实施方式Detailed ways
以下结合图表和具体实施操作对本发明作具体的介绍。The present invention will be described in detail below in combination with diagrams and specific implementation operations.
实施例一乌拉草中有效成分生物碱提取Extraction of active ingredient alkaloids in
乌拉草晾干,用电子天平称取一定量的乌拉草段,加入一定比例的溶剂,置于500ml圆底烧瓶中,80 ℃恒温水浴回流加热2 h,用纱布过滤,减压浓缩。将全部的乌拉草生物碱浓缩液,用40%氢氧化钠溶液调节pH值在8~10范围内,再用1:1体积的二氯甲烷萃取2次,合并萃取液用水洗涤直到除去溶于水的生物碱盐和碱水,收集萃取液浓缩干燥。Dried Uralia sativa, weighed a certain amount of Urassica ulata with an electronic balance, added a certain proportion of solvent, put it in a 500ml round bottom flask, heated it in a constant temperature water bath at 80 ℃ for 2 h, filtered it with gauze, and concentrated under reduced pressure. Use 40% sodium hydroxide solution to adjust the pH value in the range of 8 to 10, and then extract twice with 1:1 volume of dichloromethane, and wash the combined extracts with water until the dissolved The alkaloid salt of water and alkaline water, the extract is collected and concentrated to dryness.
实施例二化学反应鉴别Embodiment two chemical reaction identification
鉴别—显色反应:Identification - color reaction:
图1-a从左到右依次为碘-碘化钾试剂组样品及其空白对照(1-a-1和1-a-2)、浓硫酸试剂组样品及其空白对照(1-a-3和1-a-4)、浓盐酸试剂组样品及其空白对照(1-a-5和1-a-6)、钼酸铵-浓硫酸溶液组样品及其空白对照(1-a-7和1-a-8)。为了更加清晰直观的展示,1-b为放大版碘-碘化钾试剂样品(1-a-1),1-c为放大版浓硫酸试剂组(1-a-3和1-a-4),1-d为放大版钼酸铵-浓硫酸组(1-a-8和1-a-7)。Figure 1-a, from left to right, is the iodine-potassium iodide reagent group samples and their blank controls (1-a-1 and 1-a-2), the concentrated sulfuric acid reagent group samples and their blank controls (1-a-3 and 1-a-4), concentrated hydrochloric acid reagent group samples and their blank controls (1-a-5 and 1-a-6), ammonium molybdate-concentrated sulfuric acid solution group samples and their blank controls (1-a-7 and 1-a-8). For a clearer and more intuitive display, 1-b is the enlarged version of the iodine-potassium iodide reagent sample (1-a-1), 1-c is the enlarged version of the concentrated sulfuric acid reagent group (1-a-3 and 1-a-4), 1-d is an enlarged version of the ammonium molybdate-concentrated sulfuric acid group (1-a-8 and 1-a-7).
(1)碘-碘化钾试剂组:在试管中加入1~2 ml乌拉草提取液,1~2滴碘-碘化钾生物碱沉淀试剂,充分震荡。由图1-a-1、1-a-2及1-b看出碘-碘化钾试剂有橙色沉淀产生。(1) Iodine-potassium iodide reagent group:
(2)浓硫酸试剂组:秋水仙碱显黄色,可待因显淡蓝色,小檗碱显绿色,阿托品、古柯碱、吗啡和士的宁等不显色。由图1-a-3、1-a-4及1-c看出浓硫酸试剂显黄棕色。(2) Concentrated sulfuric acid reagent group: colchicine is yellow, codeine is light blue, berberine is green, atropine, cocaine, morphine and strychnine are not. It can be seen from Figure 1-a-3, 1-a-4 and 1-c that the concentrated sulfuric acid reagent is yellowish brown.
(3)浓盐酸试剂组:藜芦碱显红色,其他大部分生物碱均不显色。由图1-a-5和1-a-6可以看出浓盐酸试剂不显色。(3) Concentrated hydrochloric acid reagent group: Veratrine showed red color, but most of the other alkaloids showed no color. It can be seen from Figure 1-a-5 and 1-a-6 that the concentrated hydrochloric acid reagent does not develop color.
(4)钼酸铵-浓硫酸溶液试剂组:(Frohde试剂)为1%钼酸铵的浓硫酸溶液,称取1 g钼酸铵与烧杯中,加入100 mL浓硫酸(98%)溶解即可。乌头碱显黄棕色,吗啡显紫色转棕色,可待因显暗绿色至淡黄色,小檗碱显棕绿色,秋水仙碱显黄色,阿托品和士的宁等不显色。由图1-a-7、1-a-8及1-d看出钼酸铵-浓硫酸溶液显棕绿色,可能含有小檗碱。(4) Ammonium molybdate-concentrated sulfuric acid solution reagent group: (Frohde reagent) is a concentrated sulfuric acid solution of 1% ammonium molybdate, weigh 1 g of ammonium molybdate into a beaker, add 100 mL of concentrated sulfuric acid (98%) to dissolve Can. Aconitine is yellowish brown, morphine is purple to brown, codeine is dark green to light yellow, berberine is brownish green, colchicine is yellow, atropine and strychnine are not colored. It can be seen from Figures 1-a-7, 1-a-8 and 1-d that the ammonium molybdate-concentrated sulfuric acid solution is brownish green and may contain berberine.
以上4个显色反应说明乌拉草中存在生物碱。The above 4 color reactions show that there are alkaloids in Uralia sativa.
实施例三乌拉草生物碱含量的测定The mensuration of the alkaloid content of embodiment three Ulagrass
士的宁标准曲线的绘制Drawing of Strychnine Standard Curve
用分析天平精密称定士的宁标准品1.0 mg,加甲醇溶液定容到10 ml,摇匀,配置成0.1 mg/mL的士的宁标准品溶液。用甲醇稀释成0.004、0.006、0.008、0.012 mg/mL系列浓度梯度的士的宁标准溶液。在254 nm波长处测定士的宁的吸光度A。以士的宁浓度(mg/mL)为横坐标,吸光度值(A)为纵坐标绘制标准曲线。进行线性回归,得回归方程:Y=73.7X-0.0754,R2=0.9994,如图2。结果表明士的宁在0.04~0.012 mg/L内其浓度和吸光度呈良好的线性关系。Accurately weigh 1.0 mg of standard strychnine with an analytical balance, add methanol solution to make up to 10 ml, shake well, and prepare a 0.1 mg/mL strychnine standard solution. Diluted with methanol to 0.004, 0.006, 0.008, 0.012 mg/mL serial concentration gradient strychnine standard solution. The absorbance A of strychnine was measured at a wavelength of 254 nm. Draw a standard curve with strychnine concentration (mg/mL) as the abscissa and absorbance value (A) as the ordinate. Perform linear regression to obtain the regression equation: Y=73.7X-0.0754, R 2 =0.9994, as shown in Figure 2. The results showed that strychnine had a good linear relationship between its concentration and absorbance in the range of 0.04-0.012 mg/L.
样品的含量测定Assay of samples
取样品加入10 mL甲醇超声溶解。用移液管移取1 mL样品溶液加入到试管中,加入3 mL甲醇,摇匀,在254 nm波长处测定吸光度A,将吸光度值带入士的宁标准曲线中,测定乌拉草粗生物碱含量(mg/mL)。根据公式计算出乌拉草粗生物碱浓度,按以下公式计算乌拉草总生物碱的提取率:Take a sample and add 10 mL of methanol for ultrasonic dissolution. Use a pipette to
C:生物碱浓度;V:乌拉草生物碱提取液体积;n:稀释倍数;M:乌拉草质量。C: concentration of alkaloids; V: volume of alkaloid extract from A. ulata; n: dilution multiple; M: mass of A. ulaxa.
实施例四单因素实验Embodiment four single factor experiment
(1)盐酸浓度对乌拉草总生物碱含量的影响(1) The effect of hydrochloric acid concentration on the total alkaloid content of Uralia sativa
固定提取时间2 h,液料比20mL/g,提取温度80℃不变。精密称取每份为5g的乌拉草段分别放入200 mL的烧瓶里,选取5组盐酸浓度分别为0.06、0.12、0.18、0.24、0.30 mol/L下提取,其它步骤同上。The extraction time was fixed at 2 h, the liquid-to-solid ratio was 20 mL/g, and the extraction temperature was 80 °C. Precisely weigh 5g of Ulagrass segments into 200 mL flasks, select 5 groups of hydrochloric acid concentrations of 0.06, 0.12, 0.18, 0.24, and 0.30 mol/L for extraction, and the other steps are the same as above.
由图3结果可知,随着盐酸浓度的上升,总生物碱浓度增加,因此乌拉草总生物碱的提取率同比增大,当盐酸浓度达到0.18 mol/L时,提取率达到最大,盐酸浓度超过0.18mol/L时,提取率开始下降。From the results in Figure 3, it can be seen that with the increase of the concentration of hydrochloric acid, the concentration of total alkaloids increases, so the extraction rate of total alkaloids of A. 0.18mol/L, the extraction rate began to decline.
(2)提取温度对乌拉草总生物碱提取率的影响(2) The effect of extraction temperature on the extraction rate of total alkaloids from Uralia sativa
固定提取时间2 h,液料比20mL/g,盐酸浓度0.18 mol/L不变。精密称取每份为5g的乌拉草段分别放入200 mL的烧瓶里,选取5组提取温度,分别为60、70、80、90、100 ℃下提取,其它步骤同上。The extraction time was fixed for 2 h, the ratio of liquid to solid was 20 mL/g, and the concentration of hydrochloric acid was 0.18 mol/L. Precisely weigh 5g of Ulagrass segments and put them into 200 mL flasks respectively. Select 5 sets of extraction temperatures, 60, 70, 80, 90, and 100 °C, and the other steps are the same as above.
由图4结果可知随着温度的上升,总生物碱浓度C增加,因此乌拉草生物碱提取率同比增大,当温度达到80 ℃时,提取率达到最大,超过80 ℃时,提取率开始下降。From the results in Figure 4, it can be seen that with the increase of temperature, the concentration of total alkaloids C increases, so the extraction rate of alkaloids in Uralia sativa increases year-on-year. When the temperature reaches 80 °C, the extraction rate reaches the maximum, and when the temperature exceeds 80 °C, the extraction rate begins to decline. .
(3)料液比对乌拉草总生物碱提取率的影响(3) The effect of solid-liquid ratio on the extraction rate of total alkaloids
固定提取时间2 h,提取温度80 ℃, 盐酸浓度0.18 mol/L不变。称取5g乌拉草段五份,分别放入100 mL、200 mL、250 mL、300 mL、500 mL圆底烧瓶里,对应的液料比分别为10、20、30、40、50 mL/g进行提取,其它步骤同上。The extraction time was fixed at 2 h, the extraction temperature was 80 °C, and the concentration of hydrochloric acid was 0.18 mol/
由图5结果可知随着提取时间的延长,乌拉草总生物碱浓度不断增加,液料比达到1:30 g/mL的时候,生物碱浓度涨幅很大,30 mL/g以后随着液料比的增加,总生物碱浓度增加缓慢涨幅不大,从节约成分的角度出发,选择30 mL/g最佳。It can be seen from the results in Figure 5 that with the prolongation of the extraction time, the concentration of total alkaloids in Uralia sativa increases continuously. When the liquid-to-solid ratio reaches 1:30 g/mL, the alkaloid concentration increases greatly. The concentration of total alkaloids increased slowly and did not increase much with the increase of ratio. From the perspective of saving ingredients, the best choice was 30 mL/g.
因此,确定单因素结果为提取时间2 h时提取温度80℃、盐酸浓度为0.18 mol/L、液料比为30 mL/g的条件下,乌拉草总生物碱在每个因素中提取率最佳。Therefore, the single-factor results determined that the extraction rate of total alkaloids in Uralia sativa was the highest in each factor under the conditions of extraction temperature of 80°C, hydrochloric acid concentration of 0.18 mol/L, and liquid-to-solid ratio of 30 mL/g when the extraction time was 2 h. good.
实施例五响应面优化实验设计
在上述单因素实验的基础上,根据Box-Behnken中心组合试验设计原理和单因素试验结果,采用响应面统计分析软件以溶剂浓度(A)、提取温度(B)、液料比(C)为影响变量进行响应面实验设计,以层次分析得到的权重系数计算其乌拉草生物碱含量为相应指标,建立3因素3水平共17组实验,见表1及表2。On the basis of the above single factor experiments, according to the Box-Behnken central combination experiment design principle and the results of single factor experiments, the response surface statistical analysis software was used to set the solvent concentration (A), extraction temperature (B), and liquid-solid ratio (C) as Response surface experiment design was carried out on the influencing variables, and the weight coefficient obtained by AHP was used to calculate the alkaloid content of Uralia sativa as the corresponding index. A total of 17 experiments with 3 factors and 3 levels were established, as shown in Table 1 and Table 2.
表1 响应面试验因素水平设计Table 1 Response surface test factor level design
表2响应面分析实验方案及结果Table 2 Response surface analysis experiment scheme and results
利用统计学分析软件件Design-Expert V,对乌拉草总生物碱提取工艺进行计算与分析,根据多元回归拟合,方差分析结果见表3。以溶剂浓度(A)、提取温度(B)、液料比(C)为自变量,乌拉草总生物碱含量为响应值,得出乌拉草总生物碱含量的预测值对A、B、C编码值的二次回归模型方程:The statistical analysis software Design-Expert V was used to calculate and analyze the extraction process of the total alkaloids of A. ulata. According to the multiple regression fitting, the variance analysis results are shown in Table 3. Taking solvent concentration (A), extraction temperature (B), liquid-to-solid ratio (C) as independent variables, and total alkaloid content of Uralia ulata as the response value, the predicted value of the total alkaloid content of Uralia ulata in relation to A, B, and C The quadratic regression model equation for coded values:
Y=2.74+0.17A-0.21B+0.19C-0.37AB-8.3100E-003AC-0.74BC-0.81A2-0.61B2-0.99C2 Y=2.74+0.17A-0.21B+0.19C-0.37AB-8.3100E-003AC-0.74BC-0.81A 2 -0.61B 2 -0.99C 2
该模型的F值为17.48,意味着该模型是显著的。由于噪声,出现如此大的“模型F值”的可能性只有0.05%。“P>F”值小于0.05表示该模型项显著。在这种情况下,AB, BC, A2,B2, C2是重要的模型项。当P值>0.1时,表示模型项不显著。The F value of the model is 17.48, which means the model is significant. There is only a 0.05% chance of having such a large "model F-number" due to noise. A value of " P >F" less than 0.05 indicates that the model term is significant. In this case, AB, BC, A 2 ,B 2 , C 2 are important model terms. When the P value > 0.1, it means that the model item is not significant.
表3回归模型方差分析结果Table 3 Regression Model Analysis of Variance Results
通过图6的3D立体响应面图和2D的等高线图可以更加清楚明了的看出溶剂浓度、提取温度以及液料比对乌拉草总生物碱含量的影响。实验结果显示,溶剂浓度在0.15 mol/L~0.24 mol/L范围内,响应曲面弯曲,对乌拉草指标成分影响关系较为直观,提取温度在75~90 ℃区间内曲面相对弯曲,对乌拉草生物碱含量影响较大。在溶剂浓度为0.15 mol/L~0.24 mol/L,提取温度在75~-85 ℃时,两个因素图像倾斜度较大,说明在实验中,两个因素相互组合,此时对实验影响较为显著;而溶剂浓度和液料比两因素之间关系可以看出,溶剂浓度对其影响较为显著,液料比趋于平缓,由此可看出,在溶剂浓度和液料比因素影响下,液料比影响较小;而提取温度与液料比两因素之间的倾斜度可以看出当温度在74~85 ℃之间,较为倾斜,液料比趋于平缓,此结果表示,液料比起到辅助作用,影响效果不显著。Through the 3D three-dimensional response surface diagram and 2D contour diagram in Figure 6, the influence of solvent concentration, extraction temperature and liquid-to-solid ratio on the total alkaloid content of Uralia sativa can be seen more clearly. The experimental results show that when the solvent concentration is in the range of 0.15 mol/L~0.24 mol/L, the response surface is curved, and the influence relationship on the index components of Uralia sativa is more intuitive. The alkali content has a greater influence. When the solvent concentration is 0.15 mol/L~0.24 mol/L, and the extraction temperature is 75~-85 ℃, the image slope of the two factors is relatively large, indicating that in the experiment, the combination of the two factors has a greater impact on the experiment. It can be seen that the solvent concentration and the relationship between the two factors of the liquid-to-solid ratio can be seen that the solvent concentration has a more significant impact on it, and the liquid-to-solid ratio tends to be gentle. It can be seen that under the influence of the solvent concentration and the liquid-to-solid ratio factors, The influence of liquid-solid ratio is small; and the gradient between the two factors of extraction temperature and liquid-solid ratio can be seen that when the temperature is between 74 and 85 ℃, it is relatively inclined, and the liquid-solid ratio tends to be flat. This result shows that the liquid-solid ratio Compared with the auxiliary effect, the effect is not significant.
由图7预测模型图可以看出,各实验数据均匀分布在线性范围之内且靠近直线,并没有异常点,说明该实验的线性关系明显。其次通过对残差与方程预测值进行分析,其结果显示,各实验点分布不均,并且无规律,由此说明该实验合理可靠,误差较小,适合乌拉草总生物碱的提取工艺的优化。It can be seen from the prediction model diagram in Figure 7 that the experimental data are evenly distributed within the linear range and close to the straight line, and there are no abnormal points, indicating that the linear relationship of the experiment is obvious. Secondly, by analyzing the residual and the predicted value of the equation, the results show that the distribution of each experimental point is uneven and irregular, which shows that the experiment is reasonable and reliable, with small errors, and is suitable for the optimization of the extraction process of the total alkaloids of Uralia sativa .
实施例六乌拉草中有效成分士的宁的纯化分离Purification and separation of active ingredient strychnine in embodiment six Ulagrass
纯化与分离:预处理:选取适长(2.6cm×40cm)的层析柱,用蒸馏水清洗干净,超声5 min,防止柱子堵塞流速慢。确保层析柱流速正常后,将其自然晾干,备用。称取20 g用于柱层层析的硅胶,与适量(5~10 mL)二氯甲烷混合,用玻璃棒搅拌均匀排出气泡。在干燥的层析柱底部放置适量脱脂棉,加入一些二氯甲烷试剂浸润柱体,快速将硅胶与二氯甲烷的混合物完全倒入层析柱中。静置10 min让硅胶自然沉降后,打开柱体底部阀门。再缓缓倒入50 mL二氯甲烷于柱子里,反复洗三次。Purification and separation: Pretreatment: Select a chromatographic column of appropriate length (2.6cm×40cm), wash it with distilled water, and ultrasonicate for 5 minutes to prevent the column from clogging and the flow rate is slow. After ensuring that the flow rate of the chromatographic column is normal, let it dry naturally for later use. Weigh 20 g of silica gel for column chromatography, mix with an appropriate amount (5-10 mL) of dichloromethane, and stir with a glass rod to evenly expel air bubbles. Place an appropriate amount of absorbent cotton at the bottom of the dry chromatography column, add some dichloromethane reagent to soak the column, and quickly pour the mixture of silica gel and dichloromethane into the chromatography column completely. After standing for 10 min to allow the silica gel to settle naturally, open the valve at the bottom of the column. Then slowly pour 50 mL of dichloromethane into the column, and wash it three times repeatedly.
上样:保持柱面平整,采取干法上样减少误差。取干燥好的样品1g用少量二氯甲烷超声溶解,再低温蒸干的过程中加入硅胶粉,直至完全干燥,称重,上样。Sample loading: keep the cylindrical surface flat, and use dry method to load samples to reduce errors. Take 1 g of the dried sample and dissolve it ultrasonically with a small amount of dichloromethane, then add silica gel powder during the process of evaporating to dryness at low temperature until it is completely dry, weigh it, and load the sample.
纯化:石油醚:二氯甲烷:无水乙醇:环己烷(50:10:5:10)洗脱三个柱体积,将极性较小的杂质洗脱下来。Purification: Petroleum ether: dichloromethane: absolute ethanol: cyclohexane (50:10:5:10) for three column volumes to elute less polar impurities.
分离:换二氯甲烷:无水乙醇:环己烷(30:10:10)洗脱三个柱体积,洗脱出含有士的宁的纯化生物碱;最后用甲醇:二氯甲烷(40:10)洗脱其它极性大的生物碱,用生物碱沉淀试剂检测至洗脱样品无色。Separation: Change dichloromethane: absolute ethanol: cyclohexane (30:10:10) to elute three column volumes to elute the purified alkaloid containing strychnine; finally use methanol: dichloromethane (40: 10) Elute other alkaloids with high polarity, and detect with alkaloid precipitation reagent until the eluted sample is colorless.
实施例七乌拉草中有效成分士的宁的鉴定The identification of active ingredient strychnine in embodiment seven Ulagrass
1.化学方法鉴定:钒酸铵-浓硫酸溶液1. Identification by chemical method: ammonium vanadate-concentrated sulfuric acid solution
取生物碱酸水提取液1000 mL浓缩至150 mL,用氨水调节其pH=7。将上述溶液继续浓缩至60mL,加42mL无水乙醇萃取,离心取上清液,减压浓缩挥去乙醇。得到样品溶液,将样品溶液过AB-8柱进行纯化分离,先以蒸馏水洗脱,再以70%乙醇洗脱,共洗脱下来5份生物碱样品。流份1是经水洗得到体积为50ml,流份2、3、4、5经醇洗得到每个体积各50ml。以1%的钒酸铵-浓硫酸溶液对每份生物碱样品及士的宁对照溶液进行颜色鉴别反应。 由图8可看出5个样品显示出不同颜色,士的宁与1%的钒酸铵-浓硫酸溶液反应先出现紫色,后变为红色,其中流份3号出现的颜色变化与士的宁对照品相同,说明乌拉草中可能含有吲哚类生物碱士的宁。Concentrate 1000 mL of alkaloid acid water extract to 150 mL, and adjust its pH to 7 with ammonia water. Continue to concentrate the above solution to 60 mL, add 42 mL of absolute ethanol for extraction, centrifuge to obtain the supernatant, concentrate under reduced pressure and evaporate the ethanol. The sample solution was obtained, and the sample solution was purified and separated through an AB-8 column, first eluted with distilled water, and then eluted with 70% ethanol, and a total of 5 alkaloid samples were eluted.
2.检测紫外最大吸收波长2. Detection of UV maximum absorption wavelength
取经硅胶柱层析纯化分离后的生物碱样品和士的宁对照品,分别以甲醇定容至10mL容量瓶中(浓度为0.1 mg/mL),进行全波长扫描,测定其紫外最大吸收波长。结果显示,在254 nm处有明显的紫外吸收峰,与士的宁吸收峰一致,如图9,10所示。Take the alkaloid sample and strychnine reference substance purified and separated by silica gel column chromatography, and dilute to 10mL volumetric flask with methanol (concentration is 0.1 mg/mL), and perform full-wavelength scanning to determine the maximum ultraviolet absorption wavelength. The results show that there is an obvious ultraviolet absorption peak at 254 nm, which is consistent with the absorption peak of strychnine, as shown in Figures 9 and 10.
3.薄层色谱鉴定法3. TLC identification method
取生物碱酸水提取液100 mL,以二氯甲烷1:1萃取3次。合并萃取液,旋转浓缩至5mL左右,备用。制备对照品溶液,准确称量士的宁对照品1 mg加二氯甲烷定容至10 mL容量瓶中(0.1 mg/mL)。分别点在同一块硅胶G薄层板上,配置二氯甲烷:环己烷:乙醇(3:1:1)展开剂,展开,取出展开缸中预饱和5 min,展开,取出。喷稀碘化铋钾试液显色。由图11可以看出乌拉草生物碱样品与士的宁对照品在薄层色谱板同一位置上,显示出相同颜色和形状的斑点。Take 100 mL of alkaloid-acid water extract and
4.高效液相色谱鉴定法4. High performance liquid chromatography identification method
Shim-pack VP C18(150nm*4.6nm*5um),流动相为0.4%磷酸(以三乙胺调制pH3.0)-乙腈(85:15),流速为1.0mL/min,检测波长为260nm,柱温为25℃,梯度洗脱,进样量为20μL。Shim-pack VP C 18 (150nm*4.6nm*5um), the mobile phase is 0.4% phosphoric acid (adjust pH3.0 with triethylamine)-acetonitrile (85:15), the flow rate is 1.0mL/min, and the detection wavelength is 260nm , the column temperature was 25°C, gradient elution was performed, and the injection volume was 20 μL.
按上述色谱条件,分别取经硅胶层析纯化分离后的样品液作为供试品溶液和士的宁对照品20μL进样,样品及士的宁对照品于3.47min处有吸收峰,士的宁峰与相邻峰分离良好,结果见图12、13。According to the above-mentioned chromatographic conditions, get the sample liquid after silica gel chromatography purification and separation respectively as need testing solution and 20 μ L sample injection of strychnine reference substance, sample and strychnine reference substance have absorption peak at 3.47min place, strychnine peak It is well separated from adjacent peaks, and the results are shown in Figures 12 and 13.
综上所述,确定从乌拉草中提取的生物碱含有士的宁。In summary, it is determined that the alkaloids extracted from Uralia sativa contain strychnine.
本发明采用响应面分析方法,选取提取温度、料液比和溶剂浓度为因素,考察乌拉草生物碱的最佳提取条件,通过硅胶柱层析纯化分离生物碱,化学方法鉴定,紫外分光光度法、薄层色谱法、高效液相色谱法鉴定乌拉草生物碱中存在士的宁的成分。The present invention adopts the response surface analysis method, selects extraction temperature, material-liquid ratio and solvent concentration as factors, investigates the optimal extraction conditions of the alkaloids of A. , thin-layer chromatography, and high-performance liquid chromatography identified the components of strychnine in the alkaloids of Uralia sativa.
通过以乌拉草为原料,使用酸水回流提取其总生物碱,并利用响应面法优化其提取工艺路线,并确定其中含有士的宁,为乌拉草总生物碱的进一步开发提供一定的技术支持。对本发明的优选实施例进行说明,应当理解,此处所述的优选实例仅用于说明和解释本发明,并不用于限定本发明。The total alkaloids were extracted by acid water reflux using Uralia sativa as raw material, and the extraction process was optimized by response surface methodology, and it was confirmed that strychnine was contained in it, which provided certain technical support for the further development of the total alkaloids . The preferred embodiments of the present invention are described, and it should be understood that the preferred embodiments described here are only used to illustrate and explain the present invention, and are not intended to limit the present invention.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110848038.4A CN113694128B (en) | 2021-07-27 | 2021-07-27 | Response surface method optimized extraction process of strychnine-containing alkaloids in carex meyeriana |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110848038.4A CN113694128B (en) | 2021-07-27 | 2021-07-27 | Response surface method optimized extraction process of strychnine-containing alkaloids in carex meyeriana |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113694128A CN113694128A (en) | 2021-11-26 |
CN113694128B true CN113694128B (en) | 2022-11-08 |
Family
ID=78650750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110848038.4A Active CN113694128B (en) | 2021-07-27 | 2021-07-27 | Response surface method optimized extraction process of strychnine-containing alkaloids in carex meyeriana |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113694128B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115825316B (en) * | 2023-02-15 | 2023-06-16 | 武汉宏韧生物医药股份有限公司 | Method and device for analyzing active ingredients of medicine based on supercritical chromatography |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112438400A (en) * | 2020-11-13 | 2021-03-05 | 吉林化工学院 | Method for purifying Meyer sedge total flavonoids and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101838273B (en) * | 2010-05-17 | 2012-03-28 | 湘潭大学 | Method for Extracting Strychnine from Nuxychnium |
CN103159774B (en) * | 2011-12-09 | 2015-07-08 | 北京因科瑞斯医药科技有限公司 | Extraction, separation and purification method for strychnos total alkaloid |
-
2021
- 2021-07-27 CN CN202110848038.4A patent/CN113694128B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112438400A (en) * | 2020-11-13 | 2021-03-05 | 吉林化工学院 | Method for purifying Meyer sedge total flavonoids and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN113694128A (en) | 2021-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101653899B1 (en) | Method for extracting and separating ginkgolides | |
CN102401820A (en) | Detection method of several mycotoxins in wheat | |
CN113694128B (en) | Response surface method optimized extraction process of strychnine-containing alkaloids in carex meyeriana | |
CN106932509B (en) | The fingerprint of Qige granule and its construction method | |
CN102321135B (en) | Method for separating and purifying cordycepin by utilizing high-speed counter-current chromatography | |
CN106995425A (en) | The extraction process and its isolation and purification method of a kind of Rhizoma Belamcandae flavone aglycone | |
CN103432196A (en) | Desmodium styracifolium total flavonoids and preparation method of Desmodium styracifolium total flavonoids and total polysaccharides | |
CN108693265A (en) | The extraction and purifying of HERBA DENDROBII total alkaloid and content assaying method | |
CN106226415B (en) | Method that is a kind of while measuring six kinds of iridoid glycoside constituents in honeysuckle | |
CN101618053B (en) | Preparation process of isatis root medical solution | |
CN104280495A (en) | Method for detecting validamycin A in water and rice plants | |
CN109776515A (en) | The method of mangiferin is extracted from myrica rubra leaf | |
CN102093359B (en) | Process for extracting rhynchophylline monomers from uncaria rhynchophylla | |
CN112763609B (en) | Research method for screening and extracting process of anti-asthma active ingredients of chamomile | |
He et al. | Research progress on the separation of alkaloids from chinese medicines by column chromatography | |
CN114224951A (en) | Industrial preparation method of total alkaloids in Coptis and Evodia composition | |
CN105037311B (en) | A kind of compound liquid phase method for extraction and purification of the online two dimension of apiolin | |
CN109045087A (en) | A kind of enriching and purifying technique of Chinese sumac active component | |
CN102659549B (en) | Method for extracting brevifolin from Relinqing granula raw material and method for preparation quality control | |
CN101744887A (en) | Detection Method for Chinese medicinal composition preparation | |
CN103175906B (en) | Qualitative and quantitative detection method for each component of validamycin | |
CN116559302B (en) | Application of wall grass alkali in kadsura pepper stem sample quality detection and corresponding quality detection method | |
CN102836207A (en) | A kind of preparation of stachydrine hydrochloride extract and its quality control method | |
CN100387987C (en) | Method for determining hypocrellin A content by high efficiency liquid phase chromatographic method | |
CN103641771B (en) | A kind of method of simultaneously preparing iminosugar and chromocor extract from silkworm excrement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240118 Address after: 132001 Branch 3, Building B, Yongchang Second District, Kangzhuang Street, Changyi District, Jilin City, Jilin Province Patentee after: Jilin Yucao Workshop Technology Co.,Ltd. Address before: 132022 No. 45 Chengde street, Longtan District, Jilin, Jilin Patentee before: JILIN INSTITUTE OF CHEMICAL TECHNOLOGY |
|
TR01 | Transfer of patent right |